| Biological Sciences | Lifetime | 830 | CA 33 | 99.90 |
| Biological Sciences | 2021-2025 | 987 | CA 25 | 98.91 |
| Genetics | Lifetime | 97 | CA 7 | 99.79 |
| Cancer Research | Lifetime | 123 | CA 6 | 99.35 |
| Pathology and Forensic Medicine | Lifetime | 260 | CA 13 | 99.06 |
| Oncology | Lifetime | 524 | CA 11 | 99.04 |
| Reproductive Medicine | Lifetime | 535 | CA 19 | 95.86 |
| Genetics | 2021-2025 | 84 | CA 7 | 98.07 |
| Surgery | 2021-2025 | 834 | CA 44 | 92.64 |
| Pathology and Forensic Medicine | 2021-2025 | 356 | CA 19 | 87.17 |
| BRCA gene mutations in cancer | Lifetime | 7 | CA 2 | 99.83 |
| Congenital Diaphragmatic Hernia Studies | Lifetime | 25 | CA 3 | 99.67 |
| Cancer Genomics and Diagnostics | Lifetime | 77 | CA 3 | 99.78 |
| DNA Repair Mechanisms | Lifetime | 46 | CA 3 | 99.55 |
| Genetic factors in colorectal cancer | Lifetime | 58 | CA 2 | 99.70 |
| Genomic variations and chromosomal abnormalities | Lifetime | 74 | CA 5 | 99.13 |
| Chromatin Remodeling and Cancer | Lifetime | 21 | CA 2 | 99.22 |
| Ovarian cancer diagnosis and treatment | Lifetime | 171 | CA 8 | 99.15 |
| Cancer Mechanisms and Therapy | Lifetime | 88 | CA 3 | 98.90 |
| Cancer-related Molecular Pathways | Lifetime | 215 | CA 6 | 99.13 |
| Nutrition, Genetics, and Disease | Lifetime | 83 | CA 2 | 98.57 |
| Breast Cancer Treatment Studies | Lifetime | 297 | CA 12 | 99.03 |
| Genomics and Rare Diseases | Lifetime | 274 | CA 14 | 97.50 |
| CRISPR and Genetic Engineering | Lifetime | 659 | CA 17 | 97.83 |
| Male Breast Health Studies | Lifetime | 24 | CA 2 | 96.27 |
| HER2/EGFR in Cancer Research | Lifetime | 859 | CA 27 | 96.60 |
| Metastasis and carcinoma case studies | Lifetime | 974 | CA 4 | 94.38 |
| Breast Lesions and Carcinomas | Lifetime | 839 | CA 25 | 95.05 |
| Multiple and Secondary Primary Cancers | Lifetime | 859 | CA 26 | 92.36 |
| Gestational Trophoblastic Disease Studies | Lifetime | 452 | CA 18 | 88.01 |
| BRCA gene mutations in cancer | 2021-2025 | 19 | CA 1 | 98.92 |
| DNA Repair Mechanisms | 2021-2025 | 32 | CA 1 | 96.87 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 49 | CA 5 | 97.15 |
| Cancer Genomics and Diagnostics | 2021-2025 | 403 | CA 13 | 97.30 |
| Chromatin Remodeling and Cancer | 2021-2025 | 25 | CA 1 | 93.57 |
| Genetic factors in colorectal cancer | 2021-2025 | 259 | CA 5 | 94.65 |
| Nutrition, Genetics, and Disease | 2021-2025 | 81 | CA 4 | 92.01 |
| Genomics and Rare Diseases | 2021-2025 | 563 | CA 33 | 89.17 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 489 | CA 29 | 81.67 |
| PARP inhibition in cancer therapy | 2021-2025 | 914 | CA 28 | 78.82 |
| Cancer Mechanisms and Therapy | 2021-2025 | 751 | CA 5 | 74.84 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 613 | CA 16 | 73.78 |
| Soft tissue tumor case studies | 2021-2025 | 858 | CA 17 | 47.39 |